The Role of Hepatitis B Surface Antigen in Nucleos(t)ide Analogues Cessation Among Asian Patients With Chronic Hepatitis B: A Systematic Review-Reference-Cited by-同舟云学术

The Role of Hepatitis B Surface Antigen in Nucleos(t)ide Analogues Cessation Among Asian Patients With Chronic Hepatitis B: A Systematic Review

Published:2019-08-31 Issue:3 Volume:70 Page:1045-1055
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Liu Jiaye¹²,Li Tao³,Zhang Li¹²,Xu Aiqiang¹²

Affiliation:

1. Academy of Preventive Medicine Shandong University Jinan China

2. Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention Shandong Provincial Center for Disease Control and Prevention Jinan China

3. Department of Infectious Diseases and Hepatology the Second Hospital of Shandong University Jinan China

Funder

Taishan Scholar Program of Shandong Province

the National Natural Science Foundation of China

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30474

Reference26 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013

2. EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

3. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

4. AASLD guidelines for treatment of chronic hepatitis B

5. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher hepatitis B core-specific T cell response is associated with a lower risk of clinical relapse after discontinuation of oral antiviral treatment;Journal of Microbiology, Immunology and Infection;2024-08

2. Assessment of hepatitis B virus relapse in cancer patients receiving chemotherapy with prophylactic nucleos(t)ide analogues: Implications for overall mortality;Liver International;2024-07-10

3. Clinical trial: An open‐label, randomised trial of different re‐start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B;Alimentary Pharmacology & Therapeutics;2024-07-05

4. Long-term hepatitis B surface antigen kinetics after nucleos(t)ide analog discontinuation in patients with noncirrhotic chronic hepatitis B;Liver Research;2024-07

5. Functional cure of hepatitis B in patients with cancer undergoing immune checkpoint inhibitor therapy;Journal of Hepatology;2024-07